Aug 14, 2025 13:16
CLNN - Clene Inc. Common Stock
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
8.58 0.3 (3.5%) | --- | --- | --- | --- | 0.3 (3.5%) | --- | --- |
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
AfterHours
Earnings & Ratios
- Basic EPS:
- -0.78
- Diluted EPS:
- Basic P/E:
- -11.3846
- Diluted P/E:
- RSI(14) 1m:
- 72.41
- VWAP:
- 8.85
- RVol:
- 0.2404
Events
Period | Kind | Movement | Occurred At |
---|---|---|---|
1m | Price decrease 1m | 8.56 -0.09 (-1.01%) | Oct 15 13:34 |
1m | Price decrease 1m | 8.64 -0.1 (-1.14%) | Oct 15 13:17 |
1m | Price increase 1m | 8.86 +0.1 (+1.14%) | Oct 15 11:58 |
1m | Price increase 1m | 8.79 +0.17 (+2.0%) | Oct 15 11:56 |
1m | Price increase 1m | 8.66 +0.1 (+1.19%) | Oct 15 10:22 |
Related News
Sep 03, 2024 12:00
Jul 17, 2024 11:03
Jul 09, 2024 16:11
Jun 24, 2024 12:00
Jun 21, 2024 11:09
Jun 18, 2024 11:00
May 28, 2024 11:30
May 23, 2024 14:01
May 14, 2024 12:00